MDGL — Recent News Coverage
All news mentioning MDGL in ESEN's AI-graded feed
News stories with MDGL as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on MDGL. See /coverage/MDGL for the 30-day aggregate.
MANILATIMES.NET
·
2026-08-12
LOW
NEUTRAL
CORR0.15
Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors
$MDGL
◈ ESEN AI
Madrigal Pharmaceuticals announced a routine board appointment of John C. Reed, M.D., Ph.D., a recognized figure in pharmaceutical research and development. This represents a procedural governance update rather than a s…
SEEKINGALPHA.COM
·
2026-08-11
LOW
NEUTRAL
CORR0.15
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript
$MDGL
◈ ESEN AI
MDGL participated in Canaccord Genuity's 46th Annual Growth Conference on August 11, 2026, presenting company strategy and operational updates to institutional investors. Conference presentations represent scheduled dis…
SEEKINGALPHA.COM
·
2026-08-05
NEUTRAL
NEUTRAL
CORR0.35
Madrigal Pharmaceuticals: Semaglutide Launch No Issue, Wise Pipeline Approach (NASDAQ:MDGL)
$MDGL
◈ ESEN AI
Madrigal Pharmaceuticals (MDGL) faces intensifying competitive pressure in the obesity-treatment space as semaglutide enters the market, yet the company maintains operational resilience with its lead asset Rezdiffra. Th…
SEEKINGALPHA.COM
·
2026-07-30
NEUTRAL
NEUTRAL
CORR0.32
Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2026 Earnings Call Transcript
$MDGL
◈ ESEN AI
MDGL conducted its Q2 2026 earnings call on July 30, 2026, presenting quarterly operational and financial results to investors and analysts. Earnings call transcripts typically serve as primary disclosure vehicles for m…
INSIDERMONKEY.COM
·
2026-07-08
LOW
NEUTRAL
CORR0.15
BofA lowers its Price Target on Madrigal Pharmaceuticals, Inc. (MDGL)
$MDGL
◈ ESEN AI
Bank of America reduced its price target on Madrigal Pharmaceuticals (MDGL) by $8 per share, from $550 to $542, while maintaining a Neutral stance. This modest downward revision reflects incremental reassessment rather …
MANILATIMES.NET
·
2026-07-02
NEUTRAL
BULLISH
CORR0.42
Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
$MDGL
◈ ESEN AI
Ribo and Madrigal Pharmaceuticals (MDGL) have jointly achieved a significant candidate drug nomination milestone in their siRNA partnership targeting metabolic dysfunction-associated steatohepatitis (MASH). This advance…
MANILATIMES.NET
·
2026-06-22
LOW
NEUTRAL
CORR0.05
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
$MDGL
◈ ESEN AI
Madrigal Pharmaceuticals announced routine equity inducement awards to five new non-executive employees under its 2025 Inducement Plan, approved by the Compensation Committee on June 15, 2026. This action falls under st…
EXPLORE OTHER FILTERS